SCHEMBL25463103

SCHEMBL25463103

CC1(C)OB(c2nccc3sc4ccccc4c23)OC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 6/20 0.36
LIPG Q9Y5X9 6/20 0.36
GPR3 P46089 1/20 0.35
MAPT P10636 2/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
DUSP3 P51452 1/20 0.33
BLM P54132 1/20 0.33
PTPN5 P54829 1/20 0.33
KMT2A Q03164 1/20 0.33
PTPN11 Q06124 1/20 0.33
MCL1 Q07820 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ROCK1 Q13464 1/20 0.32
ELANE P08246 1/20 0.30
NPC1 O15118 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22698401 0.85 LPL (0.37) LPLLIPGROCK1SNCADGAT1
SCHEMBL29520293 0.77 GPR3 (0.39) LPLLIPGGPR3MAPTMEN1
SCHEMBL14951403 0.77 GPR3 (0.39) LPLLIPGGPR3MAPTMEN1
SCHEMBL18646156 0.76 MAPT (0.33) LPLLIPGGPR3MAPTMEN1
SCHEMBL18647080 0.76 MAPT (0.33) LPLLIPGGPR3MAPTMEN1
SCHEMBL18090436 0.75 LPL (0.40) LPLLIPGGPR3MAPTMEN1
SCHEMBL22479138 0.74 LPL (0.38) LPLLIPGMAPTMEN1KMT2A
SCHEMBL21616053 0.74 BRDT (0.31)
SCHEMBL31501370 0.73 CYP2A6 (0.46) LPLLIPGMAPTNPC1CYP3A4
SCHEMBL528217 0.73 CYP2A6 (0.46) LPLLIPGMAPTNPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151020-A1 HETEROCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, EHD1 LPL 917/4885LIPG 1005/4885GPR3 4426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.